{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:25:33Z","timestamp":1751433933223,"version":"3.40.3"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The emergence of catastrophic antiphospholipid syndrome (CAPS) alongside coronavirus disease 2019 (COVID-19) is of great concern, because of its high mortality and unclear mechanism. This severe disease, characterized by multiple thrombi and multisystem disorder, has notably diverse clinical presentations, which complicates its diagnosis in clinical practice. Now, we report a rare case of CAPS in a patient with COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 64-year-old patient who mainly presented with pain and swelling 2 months ago progressed gradually into multiple thrombi, including pulmonary embolism, renal embolism, and deep vein thrombosis; transient ischemic attack; multiple organ dysfunction with acute kidney injury; and necrosis of both lower limbs, left upper extremity, both ears, and penile gangrene.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>He was diagnosed as CAPS with COVID-19 by positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) testing and high-titer immunoglobulin (Ig) A anti-\u03b22-glycoprotein I antibody (anti-\u03b22GPI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Active rescue treatments such as anticoagulants, plasmapheresis, glucocorticoid pulse therapy, antibiotics, and multi-organ functional support alleviated the disease effectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Although his clinical symptoms were successfully controlled, we could not save the necrotic tissue. The patient refused to undergo limb amputation and died of necrotic tissue infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>CAPS in patients with COVID-19 is an extremely serious disease with a high mortality rate. A delay in diagnosis and treatment can result in potentially devastating consequences. Therefore, physicians should be alert to the possibility of CAPS in patients with multiple thrombi and COVID-19. Furthermore, this case serves as a foundation upon which future studies can build to investigate the possible mechanisms of IgA anti-\u03b22GPI-positive CAPS in patients with COVID-19, which may guide the exploration of potential therapeutic strategies to prevent the disease\u2019s progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041790","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:52:07Z","timestamp":1743371527000},"page":"e41790","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Coronavirus disease 2019 and catastrophic antiphospholipid syndrome: Case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Shanshan","family":"Jin","sequence":"first","affiliation":[{"name":"Physical Examination Department, Quzhou Central Blood Station, Quzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiquan","family":"Wu","sequence":"additional","affiliation":[{"name":"Physical Examination Department, Quzhou Central Blood Station, Quzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8336-154X","authenticated-orcid":false,"given":"Jian","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250328","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-020-0474-5","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.","volume":"16","author":"Merrill","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with COVID-19.","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ket126","article-title":"Seronegative antiphospholipid syndrome.","volume":"52","author":"Nayfe","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/09612033211062523","article-title":"COVID-19 and antiphospholipid antibodies: a position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION).","volume":"30","author":"Wang","year":"2021","journal-title":"Lupus"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0961203309361353","article-title":"Catastrophic antiphospholipid syndrome (CAPS): update from the \u201cCAPS Registry\u201d.","volume":"19","author":"Cervera","year":"2010","journal-title":"Lupus"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R8-20250328","doi-asserted-by":"crossref","first-page":"1129201","DOI":"10.3389\/fimmu.2023.1129201","article-title":"Antiphospholipid antibodies in patients with stroke during COVID-19: a role in the signaling pathway leading to platelet activation.","volume":"14","author":"Capozzi","year":"2023","journal-title":"Front Immunol"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the pathophysiology of the antiphospholipid syndrome.","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.3390\/ijms21238972","article-title":"The weight of IgA anti-\u03b22glycoprotein I in the antiphospholipid syndrome pathogenesis: closing the gap of seronegative antiphospholipid syndrome.","volume":"21","author":"Cabrera-Marante","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid antibodies in critically ill patients with COVID-19.","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"e000423","DOI":"10.1136\/lupus-2020-000423","article-title":"Loss of antiphospholipid antibody positivity post-thrombosis in SLE.","volume":"7","author":"Khawaja","year":"2020","journal-title":"Lupus Sci Med"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome.","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:52:45Z","timestamp":1743371565000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041790","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}